SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Elon Musks warning that tighter debt markets could trigger failures and consolidation among AI neoclouds has fueled concern about Nebiuss capital-intensive expansion and weighed on sentiment. Bulls counter that Nebius has secured financing and customer commitments, arguing it is better positioned than weaker sector peers; others remain concerned about debt access and execution risks.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

Elon Musks warning that many neocloud operators could fail or consolidate, alongside concerns about debt-heavy AI data-center expansion and tighter financing, is driving attention to IREN and its peers. Traders debate whether the comments amplify genuine funding and execution risks or are self-interested criticism, with bulls pointing to IRENs contracts and infrastructure while bears warn of further losses.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas positive Phase 3 melanoma-vaccine results with Mercks Keytruda have driven discussion, but shares sold off as traders judged the data against heightened expectations and questioned the treatments commercial potential. Bulls view the results as validation for a broader cancer-vaccine platform, while skeptics point to approval, adoption and profitability uncertainties and await evidence in other cancers.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Brazils presidential election has driven sharp swings in Brazilian stocks, including NU, as traders react to political and economic uncertainty. The community is split between viewing the selloff as a buying opportunity and waiting for the stock to stabilize, with some arguing the companys fundamentals remain strong.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs event-driven Phase 3 REGAL trial of its GPS leukemia vaccine dominates discussion, with traders focused on the final analysis triggered at 80 survival events and anticipating a possible data update around ASH. Bulls speculate the prolonged wait could reflect a survival benefit, while skeptics question the delay, the companys quiet period, and whether the blinded trial will ultimately succeed; SLS009 updates are a secondary catalyst.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Lulas election victory after markets had positioned for a Bolsonaro win prompted a sharp selloff in Brazilian shares, including Petrobras. Traders are divided between concerns about political and dividend risks under Lula and the view that the decline is an overreaction given Petrobras oil business and valuation.

iShares Inc. - iShares MSCI Brazil ETF

iShares MSCI Brazil ETF

EWZ is drawing attention after Brazils unexpected Lula victory triggered a sharp selloff, as traders worry about political and economic uncertainty and the markets apparent positioning for a Bolsonaro win. Many are bearish on Brazils outlook, while others argue the decline is an overreaction and see a potential buying opportunity.

XP, Inc. engages in the operation of technology-driven financial services platform. The firm provides customers with two principal types of offerings, financial advisory services for retail clients in Brazil, high-net-worth clients, international clients and corporate and institutional clients, and an open financial product platform providing access to over 800 investment products including equity and fixed income securities, mutual and hedge funds, structured products, life insurance, pension plans, real-estate investment funds (REITs) and others from XP, its partners and competitors. he company was founded by Guilherme Dias Fernandes Benchimol in 2001 and is headquartered in Vila Olimpia, Brazil.

XP Inc - Ordinary Shares - Class A

XP Inc. is trending as investors react to a new capital optimization plan, which includes a significant buyback program and planned dividend distributions, while the community remains divided over the firm's long-term growth prospects and the broader volatility of Brazilian financial stocks. Discussion is heavily focused on whether these capital return initiatives can stabilize the share price following a multi-year downtrend and ongoing skepticism regarding the company's reliance on specific high-volatility financial products.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCelleras ABCL635 clinical results for menopausal hot flashesand its presentation of additional Phase 1/2 safety and patient-reported dataare the dominant focus, alongside anticipation for further durability data. The reaction is largely bullish on the program and its potential, while some traders caution that expectations may be high and the stock could consolidate or sell off without stronger new evidence.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

Biotech is pulling back after a recent sector rally, with traders debating whether the weakness is a pause or a broader deterioration. IBBs hold near its 50-day moving average is cited as support, while some see large-cap biotech holding up better than smaller names.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MGNI Stock Heads For Another Month In Green: Magnite Gets Price Target Boost As Google Ad-Tech Changes Open New Growth Path 

Equity

 BofA sees 48% upside for Magnite, citing Google ad-tech remedies as a potential catalyst. 


BJ’s Wholesale’s Member Count Hits Record High At 8.5M — CFO Laura Felice Highlights Strong Execution And Continued Momentum

BJ’s Wholesale raised its adjusted EPS range for 2026 to $4.60 to $4.80 compared to a range of $4.40 to $4.60 guided during the previous quarter.


Why TD’s Analyst Think This Mid-Cap Stock May Rally, It Is Up 10% Today Already

TD Cowen said in a note that the company’s Q3 adjusted EPS beat expectations due to a lower tax rate and better margin that offset a 4.7% sales miss. 


BWXT Shares Climb On Department Of Energy’s $1.5B Contract

The Department of Energy stated that the pilot plant scope will be implemented through an Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle, valued at $1.5 billion, utilizing discrete task orders.


Magnite Retail Chatter Spikes After Stock Hits Multi-Year Highs As Analyst Flags ‘Substantial’ Benefits From Google Adtech Antitrust Ruling

The benefits that Rosenblatt estimates could accrue as early as 2026, the analysts said, adding that it sees earnings improvement from behavioral remedies and potential proceeds from settlements. 


Tidal Trust II - Hilton Small-MidCap Opportunity ETF

Neutral Sentiment

<ul class="summary-bullets"><li>BofA raised Magnite’s price target to $38 from $25, implying 48% upside.&nbsp;</li><li>The firm expects Google’s ad-tech remedies to increase Magnite’s open-web advertising share from 6% to 8%-10%.&nbsp;</li><li>A U.S. judge ordered Google to change its online ad auction practices and improve compatibility with rivals.&nbsp;</li></ul><p>Magnite Inc. (<a class="mention" data-mention="$MGNI" data-symbol-id="MGNI" href="https://stocktwits.com/symbol/MGNI" target="_blank">MGNI</a>) stock is heading for another monthly gain after BofA raised its price target, pointing to better growth prospects. The firm expects Google’s ad-tech changes to push more advertising money toward rivals like Magnite, increasing its share of open-web ads.&nbsp;</p><p><a href="https://stocktwits.com/symbol/MGNI">Magnite stock</a> edged 0.4% higher in Wednesday’s premarket. The stock has climbed 9% in September and is heading for a second straight month of gains.&nbsp;</p><h2 class="st-heading-2">BofA Raises Magnite Price Target To $38&nbsp;</h2><p>BofA raised Magnite’s price target on the advertising technology company to $38 from $25 while maintaining a Buy rating. The new price target implies a 48% upside to the stock’s last closing price.&nbsp;</p><p>Alphabet Inc,’s (GOOGL, GOOG) Google is at the center of the opportunity. BofA believes proposed remedies in the U.S. Department of Justice's ad-tech case could shift advertising dollars away from Google's AdX exchange and toward competing platforms, including Magnite.</p><p>The firm expects Magnite to gain if advertisers and publishers move more spending to other platforms. BofA estimates Magnite’s share of open-web display ads could rise to 8%-10% from about 6%, helping the company capture more of the market and boost growth.&nbsp;</p><h2 class="st-heading-2">Judge Orders Google To Loosen Ad-Tech Rules&nbsp;</h2><p>Earlier this month, a U.S. District Judge ordered Google to loosen some rules for its online ad auctions and make its technology work better with competing platforms. The court did not require Google to sell its AdX advertising exchange, as the Department of Justice had requested. However, it ordered Google to separate parts of its publisher ad server from AdX.</p><p>A compliance monitor will track Google’s progress under the changes for six years. Google plans to appeal parts of the ruling. Reacting to the judgment, B. Riley raised its price target for Magnite to $30 from $27 while keeping a ‘Buy’ rating.</p><p>The firm said Google’s planned ad-tech changes are similar to what the DOJ sought and could help independent platforms like Magnite compete more effectively. However, appeals and a slow rollout could push gains in market share and financial performance to 2028.&nbsp;</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260930_041535960_d5abe7609e.png" alt="koyfin_20260930_041535960.png" width="2400" height="1240"></figure><h2 class="st-heading-2"><a class="mention" data-mention="$MGNI" data-symbol-id="MGNI" href="https://stocktwits.com/symbol/MGNI" target="_blank">MGNI</a> Stock: Retail View&nbsp;</h2><p>On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘bearish’ territory the previous day.&nbsp;</p><p>A user&nbsp;<a href="https://stocktwits.com/Laurok1414/message/665377137">said</a>, “<a href="https://stocktwits.com/symbol/MGNI">$MGNI</a> going to be HUGE. Wall Street is slowly figuring it out.”</p><p><a class="mention" data-mention="$MGNI" data-symbol-id="MGNI" href="https://stocktwits.com/symbol/MGNI" target="_blank">MGNI</a> stock has gained nearly 18% in the past twelve months.&nbsp;</p><p>Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nke-ticks-higher-ahead-of-q1-as-short-interest-hits-record-87-m-shares-could-earnings-squeeze-the-bears/cZMFbYBRBh5">NKE Ticks Higher Ahead Of Q1 As Short Interest Hits Record 87M Shares — Could Earnings Squeeze The Bears?</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

The Magnite logo is seen displayed on a smartphone screen.

Magnite Inc. (MGNI) stock is heading for another monthly gain after BofA raised its price target, pointing to better growth prospects. The firm expects Google’s ad-tech changes to push more advertising money toward rivals like Magnite, increasing its shar

MGNI Stock Heads For Another Month In Green: Magnite Gets Price Target Boost As Google Ad-Tech Changes Open New Growth Path

Alphabet Inc Class A

Magnite Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

SMCO Tidal Trust II - Hilton Small-MidCap Opportunity ETF

Fundamentals

Latest SMCO News